Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.
AUTOR(ES)
Kawamata, J
RESUMO
Apolipoprotein E (ApoE) plays a key part in lipid metabolism both in the liver, and in the CNS. To clarify the association of ApoE polymorphism with Alzheimer's disease and vascular dementia in Japan, 13 patients with early onset (age > or = 65) sporadic Alzheimer's disease, 40 patients with late onset (age < or = 65) sporadic Alzheimer's disease, 19 patients with vascular dementia, and 49 non-demented control subjects were analysed. The results showed a significantly increased frequency of the epsilon 4 allele in the patients with late onset sporadic Alzheimer's disease (0.25), but not in the patients with early onset sporadic Alzheimer's disease (0.04) or in the patients with vascular dementia (0.13) compared with controls (0.09). The raised frequency of the epsilon 4 allele in the patients with late onset sporadic Alzheimer's disease was of a lower magnitude than that in United States and Canadian studies. This may in part be due to a lower epsilon 4 frequency in the normal Japanese population and reflect the lower morbidity from Alzheimer's disease in Japan.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1073199Documentos Relacionados
- The influence of the apolipoprotein-E polymorphism in the lipid profile of Alzheimer's disease or vascular dementia patients
- Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians
- Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease
- Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
- Chromosome changes in Alzheimer's presenile dementia.
